Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Attendo
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Demand Shifts Will Expand Elderly Care Capacity In Scandinavia
Key Takeaways Accelerated capacity expansion, regulatory tailwinds, and strong brand positioning are driving sustained revenue growth, market share gains, and higher contract win rates. Ongoing efficiency initiatives and increased financial flexibility are supporting margin improvements, strategic investments, and stable long-term earnings.
View narrative
SEK 75.00
FV
7.6% undervalued
intrinsic discount
2.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
TCI Express
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Expanding Air Express And Multimodal Services Will Boost Customer Reach And Service Levels
Key Takeaways Expansion of delivery networks and multimodal services aims to diversify revenue streams and improve margins through higher-margin offerings. Investments in automation and IT infrastructure, supported by government initiatives, are set to enhance operational efficiency and reduce costs.
View narrative
₹838.45
FV
17.0% undervalued
intrinsic discount
7.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
9 days ago
author updated this narrative
Südzucker
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expected Sugar Market Shift And Positive Fruit Trends May Improve Future Margins
Key Takeaways Sugar market deficit could increase prices, benefiting Südzucker's revenue and margins long-term. EU-Mercosur agreement introduces gradual competitive pressures, allowing strategic adaptation to protect net margins.
View narrative
€11.06
FV
8.4% undervalued
intrinsic discount
1.14%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
9 days ago
author updated this narrative
Novartis
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
China Expansion And Advanced Therapies Will Drive Future Upside
Key Takeaways Strong demand for innovative therapies and expansion in emerging markets support growth, while operational efficiency boosts margins and long-term profitability. Advancements in advanced therapies and substantial shareholder returns position the company for accelerated earnings and enhanced equity performance.
View narrative
CHF 99.21
FV
2.8% overvalued
intrinsic discount
2.24%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
82
users have followed this narrative
9 days ago
author updated this narrative
Union Bank of the Philippines
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Completion Of Citi Integration Will Enable Focus On Growth Initiatives By 2025
Key Takeaways Focus on consumer loans and strategic shifts aim to sustain high net interest margins, enhancing future revenue growth and profitability. Improved operational efficiency and increasing non-interest income from transaction services are expected to enhance earnings quality and net margins.
View narrative
₱42.58
FV
27.9% undervalued
intrinsic discount
24.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
45
users have followed this narrative
9 days ago
author updated this narrative
Strides Pharma Science
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Affordable Generics And Digital Trends Will Broaden Global Healthcare Reach
Key Takeaways Expansion in high-value generics, R&D investments, and digital transformation are driving diversified growth and long-term profitability across regulated and emerging markets. Streamlined product portfolio, cost optimization, and supply chain efficiencies are boosting margins and supporting sustainable earnings improvement.
View narrative
₹1.08k
FV
19.8% undervalued
intrinsic discount
12.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Metropolis Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Rural Market Expansion And Digitalization Will Transform Diagnostics
Key Takeaways Expansion into emerging and rural markets, along with premium test offerings, is driving higher patient volumes and improved revenue quality. Investments in technology, digitalization, and industry consolidation are boosting operational efficiency, strengthening margins, and enhancing long-term profitability.
View narrative
₹2.14k
FV
1.2% overvalued
intrinsic discount
15.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
9 days ago
author updated this narrative
Zydus Wellness
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanding Health Markets And Digital Channels Will Build Long-Term Value
Key Takeaways Expansion into high-growth wellness categories and strong brand equity are driving resilient revenue streams and supporting premium pricing power. Digital transformation and improved distribution are enhancing margin potential, while input cost stabilization aids further profitability gains.
View narrative
₹2.38k
FV
16.9% undervalued
intrinsic discount
10.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Rossari Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Capacity Expansions And Green Chemistry Will Unlock Southeast Asia Markets
Key Takeaways Capacity expansions, overseas investments, and integration of acquisitions are set to boost revenue growth, operating leverage, and strengthen earnings resilience through diversification. Ongoing R&D in green chemistry and expansion into premium, eco-friendly segments will help capture new markets, support margin growth, and align with global sustainability trends.
View narrative
₹870.00
FV
27.2% undervalued
intrinsic discount
16.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies